Contemporary pharmacological technology for treatment of cerebral venous system thrombosis

1.Antithrombotic therapy in ischemic stroke: a guide for physicians / Ed. Yu.L. Shevchenko. Moscow: Pechatnyy Gorod, 2004. 32 p. [In Russian]

2. Borodin I.Yu., Pessin Ya.M. Influence of lymfostimuleting therapy on cerebral hemodynamics status in patients who underwent craniocerebral trauma /       Sibirsky nauchny meditsinsky zhurnal=The Siberian Scientific Medical Journal. 2007. Vol. 22 (1) 83-86 [In Russian]

3. Intravascular treatment of ischemic stroke in the acute phase: clinical guidelines. Association of Neurosurgeons of Russia. Saint-Petersburg, 2015. 35 p. [In Russian]

4. Russian clinical recommendations for thrombolytic therapy for ischemic stroke. Russian Society of Neurologists. The National Association for Combating Stroke. Moscow, 2015. 49 p. [In Russian]

5. Madonov P.G., Yershov K.I., Dubrovin A.V. et al. Electron beam modification of the protein nature of drugs to improve their pharmacological properties / Meditsina I obrazovanie v Sibiri: setevoe nauchnoe izdanie=Medicine and education in Siberia: online publication. 2013. №4. URL: http://ngmu.ru/cozo/mos/article/pdf.php?id=1115. [In Russian]

6. Madonov P.G., Yershov K.I., Shilova M.A. The pharmacological properties and clinical application of Trombovazim/ Flebologiya=Phlebology. 2014. Vol. 8 (2) 90-91. . [In Russian]

7. Madonov P.G., Kinsht D.N., Yershov K.I. et al. Experience of clinical application of a new drug Trombovazim in vascular surgery / Angiologiya i sosudistaya khirurgiya=Ageology and vassel surgery. 2015. Vol. 21 (1) 99 – 104. . [In Russian]

8. Pesin Ya.M., Borodin Yu.I. Water hemostasis and lymphotropic therapy / Bishkek, 2015. . [In Russian]

9. Ageno W., Beyer-Westendorf J., Garcia D.A. et al. Guidance for the management of venous thrombosis in unusual sites // J. Thromb. Thrombolysis. 2016 (41) 129–143.

10. Bhatia, R., Hill M.D., Shobha N. et al. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action // Stroke. 2010 41(10) 2254-2258.

11. de Bruijn S.F., Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis // Stroke. 1999 (30) 484–488.

12. Canhao P., Falcao F., Ferro J.M. Thrombolytics for cerebral sinus thrombosis: a systematic review // Cerebrovasc. Dis. 2003 15(3) 159–166.

13. Ciccone A., Canhao P., Falcao F. et al. Thrombolysis for cerebral vein and dural sinus thrombosis // Cochrane Database Syst Rev. 2004 1:CD003693.

14. Coutinho J.M., De Bruijn S.F., DeVeber G. et al. Anticoagulation for cerebral venous sinus thrombosis. // Stroke. 2012 (43) e41–e42.

15. Dentali F., Gianni M., Crowther M.A. et al. Natural history of cerebral vein thrombosis: a systematic review // Blood. 2006 (108) 1129–1134.

16. Dentali F., Poli D., Scoditti U. et al. Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study // J Thromb Haemost. 2012 (10) 1297–1302.

17. Dentali F., Squizzato A., Gianni M. et al. Safety of thrombolysis in cerebral venous thrombosis: a systematic review of the literature // Thromb. Haemost. 2010 (104) 1055–1062.

18. Einhaupl K., Stam J., Bousser M.G. et al. EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients // Eur J Neurol. 2010 (17) 1229–1235.

19. Einhaupl K.M., Villringer A., Meister W. et al. Heparin treatment in sinus venous thrombosis // Lancet. 1991 (338) 597–600.

20. Emberson J., Lees K.R., Lyden P. et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials // Lancet. 2014 384(9958) 1929-1935.

21. Ferro J.M., Canhao P., Stam J. et al. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT) // Stroke. 2004 (35) 664–670.

22. Jauch E.C., Saver J.L., Adams H.P. Jr. et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association // Stroke. 2013 44(3) 870-947.

23. Lansberg M.G., O’Donnell M.J., Khatri P. et al. Antithrombotic and thrombolytic therapy for ischemic stroke // Chest. 2012 (141) e601S–e636S.

24. Martinelli I., Bucciarelli P., Passamonti S.M. et al. Long-term evaluation of the risk of recurrence after cerebral sinus-venous thrombosis // Circulation. 2010 (121) 2740–2746.

25. Miranda B., Ferro J.M., Canhao P. et al. Venous thromboembolic events after cerebral vein thrombosis // Stroke. 2010 (41) 1901–1906.

26. Saposnik G., Barinagarramenteria F., Brown R.D. Jr. et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association // Stroke. 2011 (42) 1158–1192.

27. Viegas L.D., Stolz E., Canhao P. et al. Systemic thrombolysis for cerebral venous and dural sinus thrombosis: a systematic review // Cerebovasc. Dis. 2014 (37) 43–50.

Madonov P.G. – doctor of medical sciences, professor, head of the chair for pharmacology, clinical pharmacology and evidentiary medicine, e-mail: madonov@scpb.ru

Kovaleva N.V. – postgraduate student of the chair for pharmacology, clinical pharmacology and evidentiary medicine

Yershov K.I. – candidate of medical sciences, assistant of the chair for pharmacology, clinical pharmacology and evidentiary medicine

Mishenina S.V. – candidate of medical sciences, associated professor of the chair for pharmacology, clinical pharmacology and evidentiary medicine

Kikhtenko N.V. – deputy head of research division

Timinskiy D.A. – doctor anesthetist-resuscitator